Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$11.62 CAD
Change Today +0.24 / 2.11%
Volume 11.8K
As of 2:44 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sheila M. Grant MBA

Chief Operating Officer, Cardiome Pharma Corp.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

--C$413,559
As of Fiscal Year 2014

Background*

Ms. Sheila M. Grant, MBA, has been the Chief Operating Officer at Cardiome Pharma Corp. since March 26, 2013. Ms. Grant served as the Vice President of Product Development – Vernakalant at Cardiome Pharma Corp. since April 2005. Ms. Grant served as the Vice President of Commercial Affairs of Cardiome Pharma Corp. from August 15, 2003 to April 2005. Ms. Grant appointed as Director of Finance and Administration in May 1998 and re-titled as Director of Business and Clinical ...

Read Full Background

Corporate Headquarters*

1441 CREEKSIDE DRIVE
Vancouver, British Columbia V6J 4S7

Canada

Phone: 604-677-6905
Fax: 604-677-6915

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Simon Fraser University
BS
University of Essex

Other Affiliations*

Annual Compensation*

SalaryC$240,000
Total Annual CompensationC$240,000

Stock Options*

Total Value of OptionsC$553,850
Total Number of Options100,000

Total Compensation*

Total Annual Cash CompensationC$295,500
Total Short Term CompensationC$240,000
Total Calculated CompensationC$413,559
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COM:CN C$11.62 CAD +0.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Albert David Friesen Ph.D.Founder, Chairman and Chief Executive Officer
Medicure Inc.
C$105.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOME PHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.